NCT00429442View on ClinicalTrials.gov

Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2008

Study Completion Date

March 31, 2011

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

Simvastatin

80 mg once daily

DRUG

placebo

calcium tablets once daily

Trial Locations (1)

2600

Department of Neurology, Glostrup University Hospital, Glostrup Municipality

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Anna Tsakiri

OTHER

NCT00429442 - Simvastatin as an add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis | Biotech Hunter | Biotech Hunter